GLP-Sema 10/30MG

Semaglutide is a GLP-1 receptor agonist studied for its role in appetite suppression, weight management, and metabolic health.

• May support meaningful reductions in body weight
• Studied for improved glycemic parameters and insulin sensitivity
• Research explores growing interest in cardiovascular protection
• Potential neuroprotective applications under active investigation

For research purposes only. Not intended for human consumption, veterinary use, or any purpose other than in vitro scientific research. These statements have not been evaluated by the FDA.